Medium impact
Analysis of Human DNA in Stool Samples as a Technique for Colorectal Cancer Screening
Blue Cross & Blue Shield of Mississippi·Effective Mar 31, 2025
HCPCS G0464 is officially defined as "Colorectal cancer screening; stool-based dna and fecal occult hemoglobin (e.g., kras, ndrg4 and bmp3)." HCPCS G0464 is referenced in 1 tracked payer policy change from Blue Cross & Blue Shield of Mississippi. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS G0464 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.